Contraceptives devices are a variety of products that are used for the prevention of an unwanted pregnancy.Whilst preventing unwanted pregnancies remain one of the key reasons why contraceptive devices are used, the other important function of a vast variety of contraceptive devices is to prevent the transfer of sexually transmitted diseases or infections.
LPI (LP Information)' newest research report, the “Contraceptive Devices Industry Forecast” looks at past sales and reviews total world Contraceptive Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Contraceptive Devices sales for 2023 through 2029. With Contraceptive Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Devices industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Contraceptive Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Devices.
The global Contraceptive Devices market size is projected to grow from US$ 6564 million in 2022 to US$ 9287.6 million in 2029; it is expected to grow at a CAGR of 9287.6 from 2023 to 2029.
Geographically, the market in North America presently accounts for a significant share in the global market and holds immense promise for future years as well.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Male Contraceptive Devices
Female Contraceptive Devices
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Online Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ansell
Church & Dwight
Actavis
Bayer
Merck & Co
Okamoto Industries
The Female Health Company
TodaySponge
HLL Lifecare
Agile Therapeutics
Caya
Teva Pharmaceutical
Condomi Health
Karex Industries
Medicines360
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptive Devices market?
What factors are driving Contraceptive Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptive Devices market opportunities vary by end market size?
How does Contraceptive Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Contraceptive Devices Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Contraceptive Devices by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Contraceptive Devices by Country/Region, 2018, 2022 & 2029 2.2 Contraceptive Devices Segment by Type 2.2.1 Male Contraceptive Devices 2.2.2 Female Contraceptive Devices 2.3 Contraceptive Devices Sales by Type 2.3.1 Global Contraceptive Devices Sales Market Share by Type (2018-2023) 2.3.2 Global Contraceptive Devices Revenue and Market Share by Type (2018-2023) 2.3.3 Global Contraceptive Devices Sale Price by Type (2018-2023) 2.4 Contraceptive Devices Segment by Application 2.4.1 Hospital Pharmacy 2.4.2 Retail Pharmacy 2.4.3 E-Commerce 2.4.4 Online Pharmacy 2.4.5 Others 2.5 Contraceptive Devices Sales by Application 2.5.1 Global Contraceptive Devices Sale Market Share by Application (2018-2023) 2.5.2 Global Contraceptive Devices Revenue and Market Share by Application (2018-2023) 2.5.3 Global Contraceptive Devices Sale Price by Application (2018-2023) 3 Global Contraceptive Devices by Company 3.1 Global Contraceptive Devices Breakdown Data by Company 3.1.1 Global Contraceptive Devices Annual Sales by Company (2018-2023) 3.1.2 Global Contraceptive Devices Sales Market Share by Company (2018-2023) 3.2 Global Contraceptive Devices Annual Revenue by Company (2018-2023) 3.2.1 Global Contraceptive Devices Revenue by Company (2018-2023) 3.2.2 Global Contraceptive Devices Revenue Market Share by Company (2018-2023) 3.3 Global Contraceptive Devices Sale Price by Company 3.4 Key Manufacturers Contraceptive Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Contraceptive Devices Product Location Distribution 3.4.2 Players Contraceptive Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Contraceptive Devices by Geographic Region 4.1 World Historic Contraceptive Devices Market Size by Geographic Region (2018-2023) 4.1.1 Global Contraceptive Devices Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Contraceptive Devices Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Contraceptive Devices Market Size by Country/Region (2018-2023) 4.2.1 Global Contraceptive Devices Annual Sales by Country/Region (2018-2023) 4.2.2 Global Contraceptive Devices Annual Revenue by Country/Region (2018-2023) 4.3 Americas Contraceptive Devices Sales Growth 4.4 APAC Contraceptive Devices Sales Growth 4.5 Europe Contraceptive Devices Sales Growth 4.6 Middle East & Africa Contraceptive Devices Sales Growth 5 Americas 5.1 Americas Contraceptive Devices Sales by Country 5.1.1 Americas Contraceptive Devices Sales by Country (2018-2023) 5.1.2 Americas Contraceptive Devices Revenue by Country (2018-2023) 5.2 Americas Contraceptive Devices Sales by Type 5.3 Americas Contraceptive Devices Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Contraceptive Devices Sales by Region 6.1.1 APAC Contraceptive Devices Sales by Region (2018-2023) 6.1.2 APAC Contraceptive Devices Revenue by Region (2018-2023) 6.2 APAC Contraceptive Devices Sales by Type 6.3 APAC Contraceptive Devices Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Contraceptive Devices by Country 7.1.1 Europe Contraceptive Devices Sales by Country (2018-2023) 7.1.2 Europe Contraceptive Devices Revenue by Country (2018-2023) 7.2 Europe Contraceptive Devices Sales by Type 7.3 Europe Contraceptive Devices Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Contraceptive Devices by Country 8.1.1 Middle East & Africa Contraceptive Devices Sales by Country (2018-2023) 8.1.2 Middle East & Africa Contraceptive Devices Revenue by Country (2018-2023) 8.2 Middle East & Africa Contraceptive Devices Sales by Type 8.3 Middle East & Africa Contraceptive Devices Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Contraceptive Devices 10.3 Manufacturing Process Analysis of Contraceptive Devices 10.4 Industry Chain Structure of Contraceptive Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Contraceptive Devices Distributors 11.3 Contraceptive Devices Customer 12 World Forecast Review for Contraceptive Devices by Geographic Region 12.1 Global Contraceptive Devices Market Size Forecast by Region 12.1.1 Global Contraceptive Devices Forecast by Region (2024-2029) 12.1.2 Global Contraceptive Devices Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Contraceptive Devices Forecast by Type 12.7 Global Contraceptive Devices Forecast by Application 13 Key Players Analysis 13.1 Ansell 13.1.1 Ansell Company Information 13.1.2 Ansell Contraceptive Devices Product Portfolios and Specifications 13.1.3 Ansell Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Ansell Main Business Overview 13.1.5 Ansell Latest Developments 13.2 Church & Dwight 13.2.1 Church & Dwight Company Information 13.2.2 Church & Dwight Contraceptive Devices Product Portfolios and Specifications 13.2.3 Church & Dwight Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Church & Dwight Main Business Overview 13.2.5 Church & Dwight Latest Developments 13.3 Actavis 13.3.1 Actavis Company Information 13.3.2 Actavis Contraceptive Devices Product Portfolios and Specifications 13.3.3 Actavis Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Actavis Main Business Overview 13.3.5 Actavis Latest Developments 13.4 Bayer 13.4.1 Bayer Company Information 13.4.2 Bayer Contraceptive Devices Product Portfolios and Specifications 13.4.3 Bayer Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Bayer Main Business Overview 13.4.5 Bayer Latest Developments 13.5 Merck & Co 13.5.1 Merck & Co Company Information 13.5.2 Merck & Co Contraceptive Devices Product Portfolios and Specifications 13.5.3 Merck & Co Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Merck & Co Main Business Overview 13.5.5 Merck & Co Latest Developments 13.6 Okamoto Industries 13.6.1 Okamoto Industries Company Information 13.6.2 Okamoto Industries Contraceptive Devices Product Portfolios and Specifications 13.6.3 Okamoto Industries Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Okamoto Industries Main Business Overview 13.6.5 Okamoto Industries Latest Developments 13.7 The Female Health Company 13.7.1 The Female Health Company Company Information 13.7.2 The Female Health Company Contraceptive Devices Product Portfolios and Specifications 13.7.3 The Female Health Company Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 The Female Health Company Main Business Overview 13.7.5 The Female Health Company Latest Developments 13.8 TodaySponge 13.8.1 TodaySponge Company Information 13.8.2 TodaySponge Contraceptive Devices Product Portfolios and Specifications 13.8.3 TodaySponge Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 TodaySponge Main Business Overview 13.8.5 TodaySponge Latest Developments 13.9 HLL Lifecare 13.9.1 HLL Lifecare Company Information 13.9.2 HLL Lifecare Contraceptive Devices Product Portfolios and Specifications 13.9.3 HLL Lifecare Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 HLL Lifecare Main Business Overview 13.9.5 HLL Lifecare Latest Developments 13.10 Agile Therapeutics 13.10.1 Agile Therapeutics Company Information 13.10.2 Agile Therapeutics Contraceptive Devices Product Portfolios and Specifications 13.10.3 Agile Therapeutics Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Agile Therapeutics Main Business Overview 13.10.5 Agile Therapeutics Latest Developments 13.11 Caya 13.11.1 Caya Company Information 13.11.2 Caya Contraceptive Devices Product Portfolios and Specifications 13.11.3 Caya Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Caya Main Business Overview 13.11.5 Caya Latest Developments 13.12 Teva Pharmaceutical 13.12.1 Teva Pharmaceutical Company Information 13.12.2 Teva Pharmaceutical Contraceptive Devices Product Portfolios and Specifications 13.12.3 Teva Pharmaceutical Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Teva Pharmaceutical Main Business Overview 13.12.5 Teva Pharmaceutical Latest Developments 13.13 Condomi Health 13.13.1 Condomi Health Company Information 13.13.2 Condomi Health Contraceptive Devices Product Portfolios and Specifications 13.13.3 Condomi Health Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Condomi Health Main Business Overview 13.13.5 Condomi Health Latest Developments 13.14 Karex Industries 13.14.1 Karex Industries Company Information 13.14.2 Karex Industries Contraceptive Devices Product Portfolios and Specifications 13.14.3 Karex Industries Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Karex Industries Main Business Overview 13.14.5 Karex Industries Latest Developments 13.15 Medicines360 13.15.1 Medicines360 Company Information 13.15.2 Medicines360 Contraceptive Devices Product Portfolios and Specifications 13.15.3 Medicines360 Contraceptive Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Medicines360 Main Business Overview 13.15.5 Medicines360 Latest Developments 14 Research Findings and Conclusion